|
|
Volumn 40, Issue 4, 2009, Pages 416-418
|
|
Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
ADULT;
ARTICLE;
CASE REPORT;
DISEASE CLASSIFICATION;
EYE EXAMINATION;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
HUMAN;
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;
OPTICAL COHERENCE TOMOGRAPHY;
PRIORITY JOURNAL;
RETINA MACULA EDEMA;
SUBRETINAL NEOVASCULARIZATION;
VISUAL ACUITY;
DRUG ANTAGONISM;
INJECTION;
KIDNEY FUNCTION TEST;
PATHOPHYSIOLOGY;
RETINA NEOVASCULARIZATION;
VITREOUS BODY;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE;
HUMANS;
INJECTIONS;
KIDNEY FUNCTION TESTS;
MACULAR EDEMA;
RETINAL NEOVASCULARIZATION;
TOMOGRAPHY, OPTICAL COHERENCE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
|
|
EID: 70149113793
PISSN: 15428877
EISSN: None
Source Type: Journal
DOI: 10.3928/15428877-20096030-13 Document Type: Article |
|
Times cited : (5)
|
|
References (5)
|
